Multiple studies have shown that clozapine is clearly superior to other treatment strategies for Treatment Resistant Schizophrenia (TRS). Yet, in most settings only 10 percent of patients with TRS are receiving the medication -- and the percentage is often far lower than that.
Read about staff changes at foundations from Maine to California. Interested in being a foundation president? There's an opening.
Multilingual assisters can be a lifeline for those facing critical barriers to accessing health coverage and services. HHS should use the time preceding the next open enrollment period to vigorously tackle language barriers and to deliver on the ACA’s promise of truly embracing all communities.
Steve Anderson gives us a Yuuuuuuuge edition of the latest health wonk review over at medicareresources.org, which includes a Health Affairs Blog post by David Cutler in response to the recent National Health Expenditure Projections published in Health Affairs.
July 22, 2016 | Elsewhere@ Health Affairs
On July 21, the federal government requested input from interested parties on possible alternatives to the current accommodation for employers that object to providing contraceptive coverage under the ACA’s preventive services mandate.
Since the ACA's health insurance marketplaces first took effect in 2014, news story after story has focused on premium increases. Missing from this narrative, however, is that average premiums in the individual market actually dropped significantly upon implementation of the ACA.
On July 19, 2016, the Centers for Medicare and Medicaid Services released the Federally-facilitated Marketplace (FFM) and Federally-facilitated Small Business Health Options Program (FF-SHOP) Enrollment Manual for the fourth (2017) marketplace open enrollment period.
HHS recently finalized regulations for the cornerstone non-discrimination provision of the ACA -- Section 1557. Health advocates and patient advocacy organizations lauded the final regulations, which expressly prohibit insurers from employing plan benefit designs or marketing practices that...
Heightened constitutional protection of commercial speech in the health care arena has opened up opportunities for off-label promotion without threat of liability. The recent settlement between the FDA and Amarin Corporation is the most recent example of this trend.
What are the implications to APCDs if ERISA data is not available? While the potential loss of ERISA data is viewed with concern, the Court’s decision may be not fatal to policy-relevant research.